All Products
  • Antibodies
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
抗体药类似物
Path：Home > Products > Antibodies > 抗体药类似物
Products
Products
Research Grade Fasinumab
All
  • Catalog： TD-HF909026
  • Clonality： mAb
  • Application： Research Grade Biosimilar
  • Synonyms： REGN475, SAR164877, CAS: 1190239-42-9
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Fasinumab

Catalog No. TD-HF909026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG4-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target Beta-nerve growth factor, NGFB, Beta-NGF, NGF
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P01138
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names REGN475, SAR164877, CAS: 1190239-42-9
Background Fasinumab (Anti-Human NGF) is a human IgG4 monoclonal antibody to nerve growth factor (NGF). Fasinumab can be used in acute sciatica and knee osteoarthritis (OA) studies.
Note For research use only. Not suitable for clinical or therapeutic use.